Physician profile

Bryan Groth

Foot & Ankle Surgery · Colorado Springs, CO

NPI 1235176546

$885.11

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$232.55

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Organogenesis INC. $378.33 2021-2023 Puraply
Axogen $193.75 2019
Nevro Corp. $193.43 2022-2023 Senza
Checkpoint Surgical, INC $30.36 2021-2023 Checkpoint Stimulators
Bioventus LLC $22.02 2020
Heron Therapeutics, INC. $20.01 2021
Abbvie INC. $18.18 2022
Acell, INC. $15.72 2020
Tactile Systems Technology INC $13.31 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bryan Groth

$885.11

in general payments reported 2019-2025

Years
2019-2023
Top company
Organogenesis INC.

https://glasscript.com/doctor/101753/bryan-groth

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.